Add time:07/11/2019         Source:sciencedirect.com

In this work, a series of 2-substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamide derivatives were developed as β-secretase (BACE-1) inhibitors. Supported by docking study, a small library of derivatives were designed, synthesized and biologically evaluated in vitro. In addition, the selected compounds were tested with affinity (KD) towards BACE-1, blood brain barrier (BBB) permeability and cytotoxicity. The studies revealed that the most potent analog 41 (IC50 = 4.6 μM) with high predicted BBB permeability and low cellular cytotoxicity, could serve as a good lead structure for further optimization.

We also recommend Trading Suppliers and Manufacturers of 2-{[3-cyano-6-(3-methoxyphenyl)-2-pyridinyl]sulfanyl}-N-(2,3-dichlorophenyl)acetamide (cas 445269-54-5). Pls Click Website Link as below: cas 445269-54-5 suppliers